Advance in Understanding Genome Reproduction
News Aug 01, 2013
Dr Christian Rudolph, now at the School of Health Sciences and Social Care at Brunel University, London, and Professor Robert Lloyd FRS at the University of Nottingham's Centre for Genetics and Genomics discovered that one major threat comes from the cell's own machinery for duplicating chromosomes prior to cell division. The research, which has just been published in the journal Nature, also identified some of the control measures that keep this threat at bay.
For each cycle of growth and division, millions of DNA base pairs have to be unwound and copied to duplicate chromosomes. Restricting the initiation of this replication to specific chromosome sites called origins is thought to be key to the orderly progression of subsequent events.
The two strands of the DNA double helix are locally unwound at these origins, opening a branch point at which an array of proteins are then assembled to form what is called a replication fork. Each fork motors along the DNA, unwinding and copying each strand as it proceeds until it meets the end of a chromosome or, more often, collides with another fork coming the other way.
It was generally assumed that the forks simply stop and dissociate at this stage enabling the cell to put the finishing touches to the copied DNA. However, from the new research it now appears that fork collisions often create new branch points in the DNA.
These branch points mimic features of unwound replication origins and thus have the potential to trigger assembly of new forks that proceed to re-replicate the already replicated DNA.
"We found that in the bacterium Escherichia coli, this re-replication is normally limited by the combined actions of RecG protein and enzymes that digest single-stranded DNA" said Dr Rudolph.
"Working together, these factors are capable of eliminating the new DNA branches before they can establish forks. When one or other of these factors is missing, replication initiates with high frequency wherever forks collide; when all are eliminated, the cells die, demonstrating that the failure to bring replication to a timely end can have catastrophic consequences."
"My research group had been studying RecG for more than 20 years," said Professor Lloyd, "and we had already identified RecG as an important player in genome maintenance. But this new discovery, which emerged from studies conducted initially by Dr Rudolph while at Nottingham and now continued at Brunel, came as a surprise. It raises questions about what happens in other organisms."
In humans, cells initiate replication at hundreds of initiation sites, leading to hundreds of fork collisions with every cycle of cell division. It will now be important to investigate whether fork collisions have similar potential consequences for these cells and if so to find out what factors keep such events at bay.
"After all," said Professor Lloyd, "mistakes made during the process of chromosome replication often trigger genetic instability, a well-recognised hallmark of cancer."
Single-stranded Origami Technology Drives Drug Delivery Systems and Pharmaceutical Nanofactories ForwardNews
First nanotechnological approach enables the design and replication of complex single-stranded DNA and RNA origami with potential for drug delivery and nanofabrication.READ MORE
Cracking the Code of Coenzyme Q BiosynthesisNews
Coenzyme Q is a vital cog in the body’s energy-producing machinery, a kind of chemical gateway in the conversion of food into cellular fuel. Researchers are developing new tools to shed light on CoQ function, primarily by finding and defining proteins that have a direct link to the chemical. This includes the development of a new multi-omic strategy to identify the global function of an RNA-binding protein that has long been associated with mitochondria and its role in CoQ biosynthesis.READ MORE
First Successful Gene Therapy Trial Reported for People with Hemophilia ANews
Patients with hemophilia A who received a single infusion of an investigational gene therapy showed improved levels of the essential blood clotting protein FVIII, with 11 of 13 achieving normal or near-normal FVIII levels.READ MORE